HRLTX
Price
$9.52
Change
-$0.10 (-1.04%)
Updated
Oct 10 closing price
Net Assets
60.91M
RIRCX
Price
$78.31
Change
-$0.99 (-1.25%)
Updated
Oct 10 closing price
Net Assets
118.13B
Interact to see
Advertisement

HRLTX vs RIRCX

Header iconHRLTX vs RIRCX Comparison
Open Charts HRLTX vs RIRCXBanner chart's image
Hartford Real Asset R5
Price$9.52
Change-$0.10 (-1.04%)
VolumeN/A
Net Assets60.91M
American Funds Capital Income Bldr R3
Price$78.31
Change-$0.99 (-1.25%)
VolumeN/A
Net Assets118.13B
HRLTX vs RIRCX Comparison Chart in %
View a ticker or compare two or three
VS
HRLTX vs. RIRCX commentary
Oct 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRLTX is a StrongBuy and RIRCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RIRCX has more cash in the bank: 118B vs. HRLTX (60.9M). HRLTX pays higher dividends than RIRCX: HRLTX (3.40) vs RIRCX (2.61). HRLTX was incepted earlier than RIRCX: HRLTX (15 years) vs RIRCX (23 years). HRLTX (1.27) is less costly to investors than RIRCX (0.91). HRLTX is a more actively managed with annual turnover of: 198.00 vs. RIRCX (56.00). HRLTX has a lower initial minimum investment than RIRCX: HRLTX (0) vs RIRCX (250). HRLTX annual gain was more profitable for investors over the last year : 10.94 vs. RIRCX (9.94). HRLTX return over 5 years is better than : 56.31 vs. RIRCX (47.79).
HRLTXRIRCXHRLTX / RIRCX
Total Expense Ratio0.960.91105%
Annual Report Gross Expense Ratio1.270.91140%
Fund Existence15 years23 years-
Gain YTD18.03715.324118%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets60.9M118B0%
Annual Yield % from dividends3.402.61130%
Returns for 1 year10.949.94110%
Returns for 3 years35.9247.5176%
Returns for 5 years56.3147.79118%
Returns for 10 years67.4058.14116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TNYA2.100.08
+3.96%
Tenaya Therapeutics
SKYE1.730.01
+0.58%
Skye Bioscience
DRDBU10.67N/A
N/A
Roman DBDR Acquisition Corp. II
HRMY26.54-0.02
-0.08%
Harmony Biosciences Holdings
GMED56.57-3.04
-5.10%
Globus Medical